Morphologic changes and molecular regulation of angiogenesis in pituitary adenomas

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 133-145

  De La Garcia Torre, N ^a   Wass, J A H ^a   Turner, H E ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMA; ANIMAL; GENE EXPRESSION; HUMAN; HYPOPHYSIS TUMOR; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; REVIEW; VASCULARIZATION;

ADENOMA; ANIMALS; GENE EXPRESSION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PITUITARY NEOPLASMS;

EID: 4043155768     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (73)

1. Canfield AE, Schor AM: Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci 1995;108:797-809.
2. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994;144:820-828.
3. Sharp PS: The role of growth factors in the development of diabetic retinopathy. Metabolism 1995;44(suppl 4):72-75.
4. Colville-Nash PR, Scott DL: Angiogenesis and rheumatoid arthritis: Pathogenic and therapeutic implications. Ann Rheum Dis 1992;51:919-925.
5. Brem SS, Gullino PM, Medina D: Angiogenesis: A marker for neoplastic transformation of mammary papillary hyperplasia. Science 1977;195:880-881.
6. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
7. Folkman J: Tumor angiogenesis; in Cancer Medicine, ed 4. Philadelphia, Lea & Febiger, 1993, pp 153-171.
8. Gasparini G, Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: Much more than a new prognostic tool. J Clin Oncol 1995;13:765-782.
9. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989;82:4-6.
10. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J: Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993;143:401-409.
11. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-1887.
12. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, Onoda N, Kato Y, Nitta A, Arimoto Y: Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-481.
13. Bochner BH, Cote RJ, Weidner N, Groshen S, Chen SC, Skinner DG, Nichols PW: Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 1995;87:1603-1612.
14. Dobbs SP, Hewett PW, Johnson IR, Carmichael J, Murray JC: Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br J Cancer 1997;76:1410-1415.
15. Jensen HM, Chen I, DeVault MR, Lewis AE: Angiogenesis induced by 'normal' human breast tissue: A probable marker for precancer. Science 1982;218:293-295.
16. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
17. Hanahan D, Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
18. Schechter J: Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 1972;67:109-126.
19. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW: Vasculature in nontumorous hypophyses, pituitary adenomas and carcinomas: A quantitative morphologic study. Endocr Pathol 1995;6:115-124.
20. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JAH: Angiogenesis in pituitary adenomas and the normal pituitary gland. J Clin Endocrinol Metab 2000;85:1159-1162.
21. Turner HE, Moore NR, Byrne JV, Wass JAH: Pituitary, thyroid and adrenal incidentalomas. Endocr Rel Cancer 1998;5:131-150.
22. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JAH: Angiogenesis in pituitary adenomas - Relationship to endocrine function, treatment and outcome. J Endocrinol 2000;165:475-481.
23. Jeffcoate WJ, Pound N, Sturrock ND, Lambourne J: Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1996;45:299-303.
24. Delgrange E, Trouillas J, Maiter D, Donckier J, Tourniaire J: Sex-related difference in the growth of prolactinomas: A clinical and proliferation marker study. J Clin Endocrinol Metab 1997;82:2102-2107.
25. Turner HE, Nagy Z, Esiri MM, Harris AL, Wass JAH: Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab 2000;85:2931-2935.
26. Vidal S, Kovacs K, Horvath E, Scheithauer BW, Kuroki T, Lloyd RV: Microvessel density in pituitary adenomas and carcinomas. Virchows Arch 2001;438:595-602.
27. Stanfield JP: The blood supply of the human pituitary gland. J Anat 1960;94:257-273.
28. Terayama N, Terada T, Nakanuma Y: An immunohistochemical study of tumour vessels in metastatic liver cancers and the surrounding liver tissue. Histopathology 1996;29:37-43.
29. Powell DF, Baker HL, Laws ER: The primary angiographic findings in pituitary adenomas. Radiology 1974;110:589-595.
30. Yuh WT, Fisher DJ, Nguyen HD, Tali ET, Gao F, Simonson TM, Schlechte JA: Sequential MR enhancement pattern in normal pituitary gland and in pituitary adenoma. AJNR Am J Neuroradiol 1994;15:101-108.
31. Gorczyca W, Hardy J: Microadenomas of the human pituitary and their vascularization. Neurosurgery 1988;22:1-6.
32. Schechter J, Goldsmith P, Wilson C, Weiner R: Morphological evidence for the presence of arteries in human prolactinomas. J Clin Endocrinol Metab 1988;67:713-719.
33. Elias KA, Weiner RI: Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 1984;81:4549-4553.
34. Schechter J, Ahmad N, Elias K, Weiner R: Estrogen-induced tumors: Changes in the vasculature in two strains of rat. Am J Anat 1987;179:315-323.
35. Rinerhart JF, Farquhar MG: Electron-microscopic studies of the anterior pituitary gland. J Histochem Cytochem 1953;1:93-113.
36. Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D: Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 1987;84:5775-5777.
37. Ferrara N, Henzel WJ: Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851-858.
38. Ferrara N, Winer J, Henzel WJ: Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 1992;89:698-702.
39. Ferrara N, Bunting S: Vascular endothelial growth factor, a specific regulator of angiogenesis. Curr Opin Nephrol Hypertens 1996;5:35-44.
40. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W: Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 1998;140:947-959.
41. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024-1028.
42. Jabbour HN, Boddy SC, Lincoln GA: Pattern and localisation of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland: Expression is independent of hypothalamic control. Mol Cell Endocrinol 1997;134:91-100.
43. Vidal S, Oliveira MC, Kovacs K, Scheithauer BW, Lloyd R: Immunolocalization of vascular endothelial growth factor in the GH3 cell line. Cell Tissue Res 2000;300:83-88.
44. Lohrer P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK, Renner U: Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology 2001;74:95-105.
45. Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M: Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol (Berl) 1998;96:453-462.
46. Lloyd RV, Scheithauer BW, Kuroki T, Vidal S, Kovacs K, Stefaneanu L: Vascular endothelial growth factor expression in human pituitary adenomas and carcinomas. Endocr Pathol 1999;10:229-235.
47. Ferrara N: Role of vascular endothelial growth factor in the regulation of angiogenesis. Kidney Int 1999;56:794-814.
48. Vidal S, Lloyd RV, Moya L, Scheithauer BW, Kovacs K: Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary. J Histochem Cytochem 2002;50:533-540.
49. McCabe CJ, Boelaert K, Tannahill LA, Heaney AP, Stratford AL, Khaira JS, Hussain S, Sheppard MC, Franklyn JA, Gittoes NJ: Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab 2002;87:4238-4244.
50. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaaeli R, Sasse J, Klagsbrun M:Endothelial cell-derived basic fibroblast growth factor: Synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 1987;84:2292-2296.
51. Komorowski J, Jankewicz J, Stepien H: Vascular endothelial growth factor, basic fibroblast growth factor and soluble interleukin-2 receptor concentrations in peripheral blood as markers of pituitary tumours. Cytobios 2000;101:151-159.
52. Ferrara N, Winer J, Henzel WJ: Pituitary follicular cells secrete an inhibitor of aortic endothelial cell growth: Identification as leukemia inhibitory factor. Proc Natl Acad Sci USA 1992;89:698-702.
53. Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S: Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion. J Clin Invest 1995;95:1288-1298.
54. Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D: The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001;7:569-574.
55. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR: Over-expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 1997;18:1155-1161.
56. Banerjee SK, Zoubine MN, Sarkar DK, Weston AP, Shah JH, Campbell DR: 2-Methoxyestradiol blocks estrogen-induced rat pituitary tumor growth and tumor angiogenesis: Possible role of vascular endothelial growth factor. Anticancer Res 2000;20:2641-2645.
57. Gloddek J, Pagotto U, Paez Pereda M, Arzt E, Stalla GK, Renner U: Pituitary adenylate cyclaseactivating polypeptide, interleukin-6 and glucocorticoids regulate the release of vascular endothelial growth factor in pituitary folliculostellate cells. J Endocrinol 1999;160:483-490.
58. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315-328.
59. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: An endogenous inhibitor of angiogenesis and tumour growth. Cell 1997;88:277-285.
60. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI: The 16-kDa N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 1993;133:1292-1299.
61. D'Angelo G, Martini JF, Iiri T, Fantl WJ, Martial J, Weiner RI: 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol Endocrinol 1999;13:692-704.
62. Duenas Z, Torner L, Corbacho AM, Ochoa A, Gutierrez-Ospina G, Lopez-Barrera F, Barrios FA, Berger P, Martinez de la Escalera G, Clapp C: Inhibition of rat corneal angiogenesis by 16-kDa prolactin and by endogenous prolactin-like molecules. Invest Ophthalmol Vis Sci 1999;40:2498-2505.
63. Clapp C, Sears PS, Russell DH, Richards J, Levay-Young BK, Nicoll CS: Biological and immunological characterization of cleaved and 16K forms of rat prolactin. Endocrinology 1988;122:2892-2898.
64. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA:Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 1999;96:1246-1251.
65. Woltering EA, Barrie R, O'Dorisio TM, Arce D, Ure T, Cramer A, Holmes D, Robertson J, Fassler J: Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res 1991;50:245-251.
66. Garcia de la Torre N, Wass JA, Turner HE: Anti-angiogenic effects of somatostatin analogues. Clin Endocrinol (Oxf) 2002;57:425-441.
67. Woltering EA, Watson JC, Alperin-Lea RC, Sharma C, Keenan E, Kurozawa D, Barrie R: Somatostatin analogs: Angiogenesis inhibitors with novel mechanisms of action. Invest New Drugs 1997;15:77-86.
68. Pawlikowski M, Kunert-Radek J, Grochal M, Zielinski K, Kulig A: The effect of somatostatin analog octreotide on diethylstilbestrol-induced prolactin secretion, cell proliferation and vascular changes in the rat anterior pituitary gland. Histol Histopathol 1997;12:991-994.
69. Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S: Pituitary tumor transforming gene expression in pituitary adenomas. J Clin Endocrinol Metab 1999;84:761-767.
70. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S: Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis. Nat Med 1999;5:1317-1321.
71. Heaney AP, Fernando M, Melmed S: Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002;109:277-283.
72. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S: Expression of pituitarytumour transforming gene in colorectal tumours. Lancet 2000;355:716-719.
73. Ishikawa H, Heaney AP, Yu R, Horwitz GA, Melmed S: Human pituitary tumor-transforming gene induces angiogenesis. J Clin Endocrinol Metab 2001;86:867-874.